Still fighting to cure peanut allergies
When 12-year-old Lauren Eglite saw a "What Would You Fight For?" feature about groundbreaking peanut allergy research, she asked her father, a pharmaceutical executive and Notre Dame alumnus, if he could help.That question sparked a unique partnership with Chemical and Biomolecular Engineering Professor Basar Bilgicer, leading to the creation of Artin Immunology—a startup determined to transform Bilgicer’s research into a revolutionary drug. Unlike existing treatments, Bilgicer’s approach blocks peanut allergens before they can trigger dangerous immune overreactions, without compromising the immune system itself.Now a Notre Dame student, Lauren is fighting alongside Bilgicer to advance this research, hoping to create a safer future for millions living with peanut and other allergies.Learn more at nd.edu/stories.
More from What Would You Fight For?
- 2:01Fighting to End PovertyIn Dandora, Kenya, a sprawling neighborhood in Nairobi, housing for 250,000 people is built around the city’s largest dumpsite. Life near a large trash heap exposes the population to problems ranging from illness to unemployment to extreme poverty.Many of the town’s residents spend their days wading in the trash, looking for bits of aluminum and plastic that they can exchange for a few dollars to support their family. Others, typically women, run roadside stands selling goods like fruit or medications. For many families, the profits from these microenterprises are the only way to put food on the table or to send children to school.Notre Dame and its Ford Program in Human Development Studies and Solidarity have been invested in Dandora for several years. Research projects and a Holy Cross parish have taken root. In speaking with the local population about their needs, the Ford Program asked a trio of Notre Dame economists — Wyatt Brooks, Kevin Donovan and Terry Johnson — to come to Dandora to explore problems surrounding unemployment.For more information: http://ntrda.me/FFEndPoverty
- 2:01Fighting for the Lives of ChildrenWhen your child is diagnosed with a rare, genetic disease, it feels like you’re rolling down a mountain, just waiting to hit rock bottom, says Doug Berns. When his daughter, Samantha, was diagnosed with Niemann-Pick Type C, an incurable, neurodegenerative disorder, he and his wife watched as Samantha’s energy depleted, her balance became shaky, and her laughter quieted.At Notre Dame, researchers in the Boler-Parseghian Center for Rare and Neglected Diseases seek to identify and advance treatments for a number of rare diseases, including Niemann-Pick Type C.For more information: http://ntrda.me/LivesofChildren